Select Medical (SEM) Stock Price, News & Analysis

Company Overview

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. The Concentra segment operates and provides occupational health centers, telemedicine platforms, onsite clinics, and contract services at employer worksites that deliver occupational health services, consumer health, physical therapy, and preventive care. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

Key Stats

• Today's Range: $14.85 to $15.50
• 50-Day Range: $14.22 to $18.45
• 52-Week Range: $14.03 to $40.98
• Volume: 1.46 million shs
• Average Volume: 928,122 shs
• Market Capitalization: $1.97 billion
• P/E Ratio: 9.28
• Dividend Yield: 1.63%
• Price Target: $26.00
• Consensus Rating: Moderate Buy

Select Medical Stock Analysis - MarketRank™

Select Medical scored higher than 100% of companies evaluated by MarketBeat, and ranked 1st out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Select Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Select Medical has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 4.4 / 5
• Proj. Earnings Growth: 20.51%

Earnings Growth

Earnings for Select Medical are expected to grow by 20.51% in the coming year, from $1.17 to $1.41 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Select Medical is 9.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.20.

Price to Earnings Ratio vs. Sector

The P/E ratio of Select Medical is 9.28, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.85.

Price to Earnings Growth Ratio

Select Medical has a PEG Ratio of 0.64. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Select Medical has a P/B Ratio of 1.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.78% of the float of Select Medical has been sold short.

Short Interest Ratio / Days to Cover

Select Medical has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Select Medical has recently increased by 8.36%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Select Medical pays a meaningful dividend of 1.71%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Select Medical does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Select Medical is 18.66%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Select Medical will have a dividend payout ratio of 17.73% next year. This indicates that Select Medical will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.8 / 5
• Environmental Score: -0.92

Percentage of Shares Shorted

3.78% of the float of Select Medical has been sold short.

Short Interest Ratio / Days to Cover

Select Medical has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Select Medical has recently increased by 8.36%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 4.2 / 5
• News Sentiment: 1.62

News Sentiment

Select Medical has a news sentiment score of 1.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Select Medical this week, compared to 5 articles on an average week.

Search Interest

1 people have searched for SEM on MarketBeat in the last 30 days.

MarketBeat Follows

4 people have added Select Medical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Select Medical insiders have sold 1,184.00% more of their company's stock than they have bought. Specifically, they have bought $315,420.00 in company stock and sold $4,050,000.00 in company stock.

Percentage Held by Insiders

11.60% of the stock of Select Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

89.48% of the stock of Select Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SEM Stock Analysis - Frequently Asked Questions

How have SEM shares performed this year?

Select Medical's stock was trading at $18.85 at the start of the year. Since then, SEM shares have decreased by 18.7% and is now trading at $15.32.
View the best growth stocks for 2025 here.

How were Select Medical's earnings last quarter?

Select Medical Holdings Co. (NYSE:SEM) posted its quarterly earnings data on Thursday, May, 1st. The health services provider reported $0.44 EPS for the quarter, missing analysts' consensus estimates of $0.45 by $0.01. The business's revenue for the quarter was down 24.4% compared to the same quarter last year.
Read the conference call transcript.

Is Select Medical doing a stock buyback?

Select Medical's board approved a stock buyback program on Thursday, May 1st 2025, which permits the company to buy back $1,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 42.6% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's leadership believes its shares are undervalued.

Does Select Medical have any subsidiaries?

Select Medical subsidiaries include AbsoluteCVO, ACC Capital, Actra Rehabilitation Associates, Advantage Rehabilitation Clinics, Alexandria Sports, Allevant Solutions, Ambulatory Care Solutions, and more.

Who are Select Medical's major shareholders?

Select Medical's top institutional investors include Price T Rowe Associates Inc. MD (13.81%), Vanguard Group Inc. (10.33%), T. Rowe Price Investment Management Inc. (3.14%) and Principal Financial Group Inc. (1.92%). Insiders that own company stock include Robert A Ortenzio, David S Chernow, Parvinderjit S Khanuja, Robert G Breighner Jr and Marilyn B Tavenner.
View institutional ownership trends.

How do I buy shares of Select Medical?

Shares of SEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Select Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Select Medical investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

• Record date for 3/13 Dividend: 3/03/2025
• Ex-Dividend for 3/13 Dividend: 3/03/2025
• Dividend Payable: 3/13/2025
• Last Earnings: 5/01/2025
• Record date for 5/29 Dividend: 5/15/2025
• Ex-Dividend for 5/29 Dividend: 5/15/2025
• Dividend Payable: 5/29/2025
• Today: 5/31/2025
• Next Earnings (Estimated): 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Hospitals
• Sub-Industry: Health Care Facilities
• Current Symbol: NYSE:SEM
• CIK: 1320414
• Web: www.selectmedicalcorp.com
• Phone: (717) 972-1100
• Fax: 717-972-1042
• Employees: 53,800
• Year Founded: 1996

Price Target and Rating

• Average Stock Price Target: $26.00
• High Stock Price Target: $42.00
• Low Stock Price Target: $19.00
• Potential Upside/Downside: +69.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.80
• Research Coverage: 5 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $1.34
• Trailing P/E Ratio: 9.28
• Forward P/E Ratio: 13.09
• P/E Growth: 0.64
• Net Income: $243.49 million
• Net Margins: 3.23%
• Pretax Margin: 6.63%
• Return on Equity: 14.04%
• Return on Assets: 3.32%

Debt

• Debt-to-Equity Ratio: 1.37
• Current Ratio: 1.13
• Quick Ratio: 1.13

Sales & Book Value

• Annual Sales: $5.22 billion
• Price / Sales: 0.38
• Cash Flow: $2.91 per share
• Price / Cash Flow: 5.26
• Book Value: $12.07 per share
• Price / Book: 1.27

Miscellaneous

• Outstanding Shares: 128,539,000
• Free Float: 104,687,000
• Market Cap: $1.97 billion
• Optionable: Optionable
• Beta: 1.40